For laboratory research use only

HealthyWelness
Account Cart0

How to Read a Peptide Certificate of Analysis

A certificate of analysis reports purity, identity and content. What each number means, what it does not cover, and which omissions matter most.

AI illustration of autosampler vials and analytical laboratory equipment.

Cover illustration: AI-generated editorial artwork. Conceptual only; not an exact molecular structure, actual laboratory result or evidence of clinical effects.

A certificate of analysis is the only direct evidence you have about what is in a particular vial. It is also routinely misread, usually by treating one number as a summary of quality. This is what each line means, and what a certificate does not tell you.

For laboratory research use only. The research materials supplied by HealthyWelness are not approved medicines, foods or cosmetics and are not for human or veterinary use. This article summarises published research and is not medical advice.

The three questions a certificate answers

QuestionReported asUsual method
Is it the right molecule?Identity confirmationMass spectrometry
How much of the peptide material is correct?Purity, as a percentageHPLC peak area
How much of the vial weight is peptide?Peptide contentNitrogen analysis, UV, or amino acid analysis

These are three distinct measurements. A certificate giving only the first two is incomplete for any work where absolute concentration matters.

Purity: what the percentage is a percentage of

HPLC purity is the target peptide peak area as a proportion of total detected peak area. That phrasing carries two limitations.

Only detected peaks count. Detection is typically by UV absorbance around 214 or 220 nm, which responds to the peptide bond. A non-peptide contaminant that does not absorb there is invisible to the measurement and so is excluded from the denominator. Salts and counterions fall into this category.

Only resolved peaks count. An impurity that co-elutes with the target peptide is counted as target peptide. This is not a hypothetical concern: the impurities most likely to co-elute are the ones most structurally similar to the target, such as single-residue deletions or diastereomers.

The 2018 study by Li and colleagues on synthetic human C-peptide illustrates how much work identifying and quantifying structurally related impurities actually requires — high-resolution LC-MS rather than a purity figure. The 2024 regulatory-focused review by Kuril and colleagues covers what full characterisation involves.

Peptide content: the number people forget

Weigh out 10 mg of lyophilized peptide and you do not have 10 mg of peptide. The powder also contains:

  • Water. Peptides are hygroscopic; residual and absorbed water is routinely several percent.
  • Counterions. Peptides carry charge and arrive as salts. Trifluoroacetate from purification, or acetate after exchange, can be a substantial mass fraction for highly charged peptides.
  • Residual salts from synthesis and purification.

For a basic peptide with several charged residues, these together can account for a double-digit percentage of the vial weight. If a protocol specifies a molar concentration and you calculate from gross weight, the actual concentration is lower than intended — systematically, not randomly.

Use the peptide content figure where it is given. Our reconstitution calculator works from the mass you enter, so entering net peptide mass rather than vial weight is what makes the result correct.

Why mass spectrometry needs chromatography beside it

Mass spectrometry confirms that the molecules present have the expected mass. Several meaningful differences leave mass unchanged:

DifferenceChanges mass?Detected by
Wrong residue insertedUsually yesMS
Missing residueYesMS
D-amino acid in place of LNoChiral or careful reverse-phase HPLC
Two residues transposedNoHPLC, or MS/MS fragmentation
Disulfide formed in the wrong placeNoHPLC, peptide mapping

This is why a certificate reports both, and why the HPLC chromatogram is more informative than the purity number alone. A single sharp peak and a cluster of partly resolved peaks summing to the same area give the same percentage and mean different things. Ask for the trace if the number is doing important work in your experiment.

What is typically absent, and when it matters

ItemMatters most for
Endotoxin contentAny immune or inflammatory readout — endotoxin alone produces inflammatory responses
Counterion identity and amountCell culture; trifluoroacetate has documented effects on cells at sufficient levels
Water contentAccurate weight-based concentration
Chromatogram and spectrumJudging whether the purity figure is well supported
Chirality verificationPeptides containing D-amino acids by design

The endotoxin point deserves emphasis, because it produces false positives rather than null results. If a peptide preparation carries endotoxin and the readout is cytokine release or immune cell activation, the response may belong to the contaminant. The 2008 paper by Currier and colleagues documented impurities in commercial synthetic peptides and their consequences for immunological assessment — the clearest published demonstration that this is a practical problem, not a theoretical one.

The reference standard question

A purity measurement compares a sample against something. For well-characterised peptides, reference standards exist; for most research peptides they do not, so purity is assessed by relative peak area within the sample itself rather than against an external standard.

The 2023 paper by McCarthy and colleagues in Pharmaceutical Research sets out why reference standards matter for synthetic peptide quality. The practical implication for research material is modest but real: a purity figure derived without an external standard is a statement about internal composition, not a traceable measurement, and two suppliers’ figures are not strictly comparable.

A short checklist

  • Is peptide content reported, or only purity? If only purity, weight-based concentrations will be high.
  • Is the counterion named? Relevant for cell work and for mass calculations.
  • Is the observed mass given, not just a pass statement? Compare it against the expected mass yourself, including modifications such as acetylation or amidation.
  • Is the lot number on the certificate the lot number on the vial? Certificates are lot-specific; a generic one is not evidence about your material.
  • Is the method stated for each figure? A purity number without a method cannot be interpreted.

Every lot we ship carries its own certificate rather than a representative one — our BPC-157 research material is a worked example, with the HPLC purity figure, the observed mass and the lot number on one page.

Open questions

  • How much do purity figures differ between suppliers for the same peptide when measured by one laboratory?
  • What counterion levels are tolerated in common cell culture systems?
  • Where would reference standards most improve comparability across the research peptide market?

Frequently asked questions

What is a peptide certificate of analysis?

A document accompanying a lot of material that reports the analytical results obtained for that lot. It typically includes a purity figure from HPLC, an identity confirmation from mass spectrometry, and may include peptide content, water content and counterion information.

Does 99 percent purity mean the vial is 99 percent peptide?

No. HPLC purity is the proportion of the peak area attributable to the target peptide among detected peaks. The vial also contains water, counterions such as acetate or trifluoroacetate, and any residual salts, which are not part of that calculation. Peptide content is the separate figure that addresses this.

What is the difference between purity and peptide content?

Purity describes how much of the peptide material is the correct peptide. Peptide content describes what fraction of the total weight in the vial is peptide at all. A lot can be 99 percent pure and still be well under 99 percent peptide by weight.

Why does mass spectrometry alone not confirm identity?

Mass spectrometry measures mass. Several differences do not change mass, including D versus L amino acid substitution and some sequence rearrangements. Chromatographic separation is what resolves these, which is why both methods appear on a certificate.

What is usually missing from a certificate of analysis?

Commonly absent items include endotoxin content, counterion identity and amount, water content, and chromatograms rather than summary numbers. Whether each matters depends on the experiment.

References

  1. Currier JR, et al. Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment. Clin Vaccine Immunol. 2008. PMID: 18077621 https://pubmed.ncbi.nlm.nih.gov/18077621/
  2. McCarthy D, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023. PMID: 36949371 https://pubmed.ncbi.nlm.nih.gov/36949371/
  3. Kuril AK, et al. Analytical considerations for characterization of generic peptide product: A regulatory insight. Anal Biochem. 2024. PMID: 39089363 https://pubmed.ncbi.nlm.nih.gov/39089363/
  4. Li M, et al. Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography-high resolution mass spectrometry. Anal Bioanal Chem. 2018. PMID: 29862433 https://pubmed.ncbi.nlm.nih.gov/29862433/
  5. Stalmans S, et al. Quality control of cationic cell-penetrating peptides. J Pharm Biomed Anal. 2016. PMID: 26397208 https://pubmed.ncbi.nlm.nih.gov/26397208/

For laboratory research use only. The research materials supplied by HealthyWelness are not approved medicines, foods or cosmetics and are not for human or veterinary use. This article summarises published research and is not medical advice.

Sources

  1. Currier JR, et al. Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment. Clin Vaccine Immunol. 2008. PMID: 18077621
  2. McCarthy D, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023. PMID: 36949371
  3. Kuril AK, et al. Analytical considerations for characterization of generic peptide product: A regulatory insight. Anal Biochem. 2024. PMID: 39089363
  4. Li M, et al. Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography-high resolution mass spectrometry. Anal Bioanal Chem. 2018. PMID: 29862433
  5. Stalmans S, et al. Quality control of cationic cell-penetrating peptides. J Pharm Biomed Anal. 2016. PMID: 26397208
Chat on WhatsAppMon–Sat, 09:00–21:00 (UTC+8)